CS208732B2 - Method of making the new amines - Google Patents

Method of making the new amines Download PDF

Info

Publication number
CS208732B2
CS208732B2 CS776486A CS311980A CS208732B2 CS 208732 B2 CS208732 B2 CS 208732B2 CS 776486 A CS776486 A CS 776486A CS 311980 A CS311980 A CS 311980A CS 208732 B2 CS208732 B2 CS 208732B2
Authority
CS
Czechoslovakia
Prior art keywords
compounds
sulfonene
acid
ethylamino
methoxy
Prior art date
Application number
CS776486A
Other languages
Czech (cs)
English (en)
Inventor
Enar I Carlsson
Gustav B Samuelsson
Bo T Lundgren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of CS208732B2 publication Critical patent/CS208732B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Epoxy Compounds (AREA)
CS776486A 1976-10-07 1977-10-06 Method of making the new amines CS208732B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7611125A SE416545B (sv) 1976-10-07 1976-10-07 Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat

Publications (1)

Publication Number Publication Date
CS208732B2 true CS208732B2 (en) 1981-09-15

Family

ID=20329066

Family Applications (5)

Application Number Title Priority Date Filing Date
CS776486A CS208732B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
CS776486A CS208731B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
CS776486A CS208734B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
CS776486A CS208730B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
CS776486A CS208733B2 (en) 1976-10-07 1977-10-06 Method of making the new amines

Family Applications After (4)

Application Number Title Priority Date Filing Date
CS776486A CS208731B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
CS776486A CS208734B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
CS776486A CS208730B2 (en) 1976-10-07 1977-10-06 Method of making the new amines
CS776486A CS208733B2 (en) 1976-10-07 1977-10-06 Method of making the new amines

Country Status (22)

Country Link
JP (1) JPS5346928A (xx)
AT (1) AT351509B (xx)
AU (1) AU516727B2 (xx)
BE (1) BE859474A (xx)
CA (1) CA1093096A (xx)
CH (1) CH636337A5 (xx)
CS (5) CS208732B2 (xx)
DD (1) DD132195A5 (xx)
DE (1) DE2743493A1 (xx)
DK (1) DK145375C (xx)
FI (1) FI772936A (xx)
FR (1) FR2367054A1 (xx)
GB (1) GB1589838A (xx)
HU (1) HU177638B (xx)
IE (1) IE45938B1 (xx)
LU (1) LU78263A1 (xx)
NL (1) NL7710941A (xx)
NO (1) NO145436C (xx)
NZ (1) NZ185318A (xx)
SE (1) SE416545B (xx)
SU (3) SU735166A3 (xx)
ZA (1) ZA775603B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD150456A5 (de) * 1979-03-01 1981-09-02 Ciba Geigy Ag Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols
GB8519154D0 (en) * 1985-07-30 1985-09-04 Ici Plc Aromatic ethers
JPH0627370B2 (ja) * 1985-08-23 1994-04-13 日本エステル株式会社 ポリエステル異形断面太細糸
GB8925032D0 (en) * 1989-11-06 1989-12-28 Ici Plc Chemical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE590054A (fr) * 1959-04-22 1960-10-24 Pfizer Alkylamines et leur préparation.
GB1264128A (xx) * 1968-06-29 1972-02-16
GB1433920A (en) * 1973-10-01 1976-04-28 Ici Ltd Alkanolamine derivatives

Also Published As

Publication number Publication date
ZA775603B (en) 1978-06-28
AU2930077A (en) 1979-04-12
CS208734B2 (en) 1981-09-15
SU735166A3 (ru) 1980-05-15
CS208733B2 (en) 1981-09-15
CS208731B2 (en) 1981-09-15
AU516727B2 (en) 1981-06-18
NZ185318A (en) 1980-02-21
ATA702177A (de) 1979-01-15
LU78263A1 (xx) 1978-06-09
CS208730B2 (en) 1981-09-15
IE45938L (en) 1978-04-07
DK145375B (da) 1982-11-08
SE416545B (sv) 1981-01-19
FI772936A (fi) 1978-04-08
SU959623A3 (ru) 1982-09-15
JPS5346928A (en) 1978-04-27
NO145436C (no) 1982-03-24
DE2743493A1 (de) 1978-04-13
GB1589838A (en) 1981-05-20
NO145436B (no) 1981-12-14
NO773406L (no) 1978-04-10
CA1093096A (en) 1981-01-06
FR2367054A1 (fr) 1978-05-05
SE7611125L (sv) 1978-04-08
IE45938B1 (en) 1983-01-12
FR2367054B1 (xx) 1981-11-06
BE859474A (fr) 1978-04-07
AT351509B (de) 1979-07-25
DD132195A5 (de) 1978-09-06
CH636337A5 (en) 1983-05-31
DK145375C (da) 1983-04-11
DK443177A (da) 1978-04-08
HU177638B (en) 1981-11-28
NL7710941A (nl) 1978-04-11
SU784760A3 (ru) 1980-11-30

Similar Documents

Publication Publication Date Title
US3876802A (en) Phenoxy-hydroxypropylamines, method and pharmaceutical preparations for treating cardiovascular diseases
BG61420B2 (bg) 3-метилов естер 5-етилов естер на 2,6-диметил-4-(2,3- дихлорофенил)-1,4-дихидропиридин-3,5-дикарбоксиловата киселина,притежаващ хипотензивни свойства,метод за неговото получаване и фармацевтични препарати, които ги съдържат
US4234595A (en) 3-Indolyl-tertiary butylaminopropanols
JPH0236177A (ja) 新規鏡像体及びその単離法
CS208663B2 (en) Method of making the new r,s-n-/2-phenyl-2-hydroxyethyl0 -1-alkyl-3-/4-substituted phenyl/propylamines
FI63745B (fi) Foerfarande foer framstaellning av nya terapeutiskt vaerdefulla aminer
CS202035B2 (en) Process for preparing new p-hydroxyphenoxypropanolamines
US3996382A (en) Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
BG60835B2 (bg) Епинен естер, метод за получаването му и лекарства
NO174803B (no) Enantiomerseparasjon av Cimaterol
US4528289A (en) Corynantheine derivates, processes for their preparation, and their use
US3949088A (en) Substituted phenoxy propanol amines used for treating cardiovascular diseases
CS208732B2 (en) Method of making the new amines
NO792113L (no) Membranstabiliserende forbindelser som har beta-receptor blokkerende aktivitet, deres fremgangsmaate samt fremgangsmaate for behandling av arrhytmetiske tilstander, og farmasoeytiske preparater som inneholder disse
US4263325A (en) β-Receptor blocking compounds and treatment of cardiovascular disorders therewith
IE63546B1 (en) N-[2-(4-carboxymethoxyphenyl)-1-methylethyl]-2-hydroxy-2-(3-chlorophenyl) ethane amine the methyl ester salt and stereoisomeric forms thereof
CS239935B2 (en) Precessing of substituted ncarboxyamidealkyl-fenoxypropan amine
CA1048549A (en) Pharmacologically active n-butylamine derivatives and process for the preparation thereof
US4145442A (en) Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases
JPS6334865B2 (xx)
US4603019A (en) N-(methoxyphenacyl)-amine derivatives
US5266599A (en) Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject
US4026925A (en) Active derivatives of methylamine, therapeutic compositions containing the same and processes for preparing the said derivatives and compositions
IE42131B1 (en) New aryloxy n-aralkyl propanolamines,their preparation andpharmaceutical compositions containing them
US4215134A (en) 4-Hydroxy-2-benzimidazoline-thione compounds and pharmaceutical compositions containing them